Kestra Medical Technologies, Ltd. Common Stock
KMTSKestra Medical Technologies, Ltd. is a medical device company focused on developing and commercializing innovative cardiac mapping and electrophysiology solutions. The company's products aim to improve the diagnosis and treatment of arrhythmias through advanced visualization and mapping technologies designed to enhance procedural efficiency and outcomes in electrophysiology procedures.
Company News
Kestra Medical Technologies (Nasdaq: KMTS), a wearable medical device and digital healthcare company, has been named a finalist in the 'Deal of the Year' category for the 2026 GeekWire Awards. The recognition is for the company's successful 2025 initial public offering, which the company states strengthens its ability to invest in growth and acce...
Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026. The company focuses on transforming patient outcomes in cardiovascular disease through monitoring and therapeutic intervention technologies.
Kestra Medical Technologies will report its second quarter fiscal 2026 financial results on December 11, with a conference call scheduled at 4:30 p.m. Eastern Time. The call will be available via webcast on their investor relations website.
Kestra Medical Technologies is conducting a public offering of 6,000,000 common shares at $23.00 per share, expecting to raise $138 million. The offering includes an option for underwriters to purchase an additional 900,000 shares.
Kestra Medical Technologies plans to offer 5,500,000 common shares through an underwritten public offering, with potential for an additional 825,000 shares. The proceeds will support sales, marketing, research, development, and general corporate purposes.
